OcuCure Therapeutics' Unattributed - VI Round

OcuCure Therapeutics raised a round of funding on June 21, 2011.

OcuCure Therapeutics is an ophthalmic pharmaceutical company developing new drugs. The company's lead compound has been formulated as a topical eye drop for both Age-related Macular Degeneration (AMD)…

Articles about OcuCure Therapeutics' Unattributed - VI Round: